PD-1/PD-L1 immunotherapy

PD-1/PD-L1 inhibitors

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PD-1/PD-L1 immunotherapy, covering 2025-07-15 to 2025-07-15. Get the full timeline:

Most recent: Clinical Trial Update: Tauroursodeoxycholic Acid Combined With PD-1/PD-L1 Immunotherapy in Advanced Hepatocellular Carcinoma: A Prospective Study [Phase 2]

See pricing